These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1363672)

  • 1. [The third generation of b-blockers: new possibilities ].
    Iagenskiĭ AV; Barsukov BP
    Kardiologiia; 1992; 32(11-12):98-103. PubMed ID: 1363672
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipid lowering therapy in the treatment and secondary prevention of ischemic heart disease].
    Zimin IuV
    Kardiologiia; 2003; 43(4):74-83. PubMed ID: 12968608
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy of beta-selective blocker with vasodilatating features celiprolol in patients with mild and moderate hypertension].
    Pogosova GV; Zhidko NI; Mikheeva TG; Gudkova OA; Tikhomirova EA
    Kardiologiia; 2003; 43(3):24-7. PubMed ID: 12913979
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial.
    Johnston GD; Vyssoulis G; Feely J; Holden RD; Radley DR
    J Hum Hypertens; 1995 Feb; 9(2):123-9. PubMed ID: 7752174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adrenergic mechanisms and their significance for plasma lipid concentrations].
    Day JL
    Wien Med Wochenschr; 1982; 132 Spec No 2():19-22. PubMed ID: 6132497
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol].
    Franz N; Modersohn D; Linss G; Heublein B; Gola G; Bruch L; Walde T
    Radiol Diagn (Berl); 1990; 31(6):625-8. PubMed ID: 1982742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
    Saner H; Seiler A; Mahler F
    Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of selective long-acting beta-blocker with vasodilating activity celiprolol in patients with essential hypertension].
    Podzolkov VI; Mozharova LG
    Kardiologiia; 2002; 42(10):22-6. PubMed ID: 12494052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of Minipress and Hypothiazid therapy on plasma lipoprotein lipids].
    Farsang C; Péter M; Balás-Eltes A; Fehér J
    Orv Hetil; 1987 Jun; 128(24):1253-6. PubMed ID: 2886965
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of glucose tolerance during treatment with celiprolol in patients with mild arterial hypertension without diabetes mellitus. The Genker General Practitioners.
    Van Mieghem W
    Acta Clin Belg; 1997; 52(6):360-6. PubMed ID: 9489131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers.
    Bursey RF
    Can J Gastroenterol; 1998; 12(8):542-3. PubMed ID: 9926263
    [No Abstract]   [Full Text] [Related]  

  • 12. [Celiprolol improves glucose metabolism in essential hypertension].
    Oksa A; Fedelesová V; Spustová V; Dzúrik R
    Vnitr Lek; 1998 Feb; 44(2):63-7. PubMed ID: 9820078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daytime-selective antihypertensive activity of celiprolol.
    Cleophas TJ; van der Meulen J; van de Luit L; Zwinderman AH
    Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and hemodynamic effects of celiprolol in essential hypertension.
    Parati G; Ravogli A; Bragato R; Omboni S; Mutti E; Mancia G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S14-21. PubMed ID: 2481785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celiprolol and risk factor reversal in hypertension.
    Taylor SH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S33-9. PubMed ID: 2481788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety and efficacy of celiprolol in hypertensive patients with chronic obstructive lung disease].
    Chahuán M; Corradi L; Román O; Bravo C
    Rev Med Chil; 2000 Jan; 128(1):59-63. PubMed ID: 10883523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-blockers and nitrates in patients with peripheral arterial occlusive disease: long-term findings.
    Schweizer J; Kaulen R; Nierade A; Altmann E
    Vasa; 1997; 26(1):43-6. PubMed ID: 9068264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipid peroxidation and antioxidant defense system in myocardial ischemia].
    Barsel' VA; Syrkin AL; Eliubaeva ID; Kogan IG; Vakhliaev VD; Aksiutina MS; Arkhipova TV; Shchedrina IS
    Dokl Akad Nauk; 1996 Dec; 351(5):706-8. PubMed ID: 9102090
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid profile improvement following celiprolol.
    Herrmann JM; von Heyman F; Freischütz G
    J Int Med Res; 1988; 16 Suppl 1():39A-46A. PubMed ID: 2906016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blocking agents and plasma lipids: an update.
    Harvengt C; Desager JP; Heller F; Hulhoven R
    Adv Exp Med Biol; 1987; 210():195-200. PubMed ID: 2884823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.